Tethys Bioscience Raises $25 Million in Series D Financing
Posted by: DrugsNews on: 10 Nov, 2009
Tethys Bioscience Raises $25 Million in Series D Financing
Tethys Bioscience, a privately held company, announced today that it has closed a $25 million Series D round of financing led by aeris CAPITAL AG and including Wasatch Advisors as a new investor.
Read more about Tethys Bioscience Raises $25 Million in Series D Financing
Get pricing and discount on generic medicines for Diabetes from www.roxpharmacy.com
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- Tethys Bioscience Announces Personnel Additions and Promotions
- Metabolex, Inc. Closes $8.6 Million Financing Round
- UTEP’s new $42 million, 140,000-square-foot Bioscience Research Building opens
